How to buy Dyne Therapeutics stock (Dyne Therapeutics)

Dyne Therapeutics is a biotechnology business based in the US. Dyne Therapeutics shares (DYN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $23.99 – a decrease of 6.76% over the previous week. Dyne Therapeutics employs 173 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Dyne Therapeutics Inc stock

Buy Dyne Therapeutics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Dyne Therapeutics stock price (NASDAQ: DYN)

Use our graph to track the performance of DYN stocks over time.

Dyne Therapeutics shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$23.99
52-week range	$12.06 - $47.45
50-day moving average more info button	$30.18
200-day moving average more info button	$32.71
Wall St. target price	$50.42
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-3.58

Is it a good time to buy Dyne Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dyne Therapeutics price performance over time

Historical closes compared with the close of $23.99 from 2024-12-20

1 week (2024-12-13)	-6.76%
1 month (2024-11-22)	-19.20%
3 months (2024-09-20)	-34.44%
6 months (2024-06-21)	-31.50%

1 year (2023-12-22)	89.64%
2 years (2022-12-22)	80.65%
3 years (2021-12-22)	93.31%
5 years (2019-12-18)	N/A

Is Dyne Therapeutics stock undervalued or overvalued?

Valuing Dyne Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Dyne Therapeutics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Dyne Therapeutics's PEG ratio

Dyne Therapeutics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.19. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Dyne Therapeutics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

However, it's sensible to consider Dyne Therapeutics's PEG ratio in relation to those of similar companies.

• Regeneron Pharmaceuticals (REGN.US): 1.06
• Vir Biotechnology (VIR.US): 0.00

Dyne Therapeutics financials

Gross profit TTM	$0
Return on assets TTM	-40.35%
Return on equity TTM	-68.68%
Profit margin	0%
Book value	$6.93
Market Capitalization more info button	$2.5 billion

TTM: trailing 12 months

Dyne Therapeutics share dividends

We're not expecting Dyne Therapeutics to pay a dividend over the next 12 months.

You may also wish to consider:

Dyne Therapeutics share price volatility

Over the last 12 months, Dyne Therapeutics's shares have ranged in value from as little as $12.06 up to $47.45. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Dyne Therapeutics's is 1.095. This would suggest that Dyne Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

To put Dyne Therapeutics's beta into context you can compare it against those of similar companies.

• Regeneron Pharmaceuticals (REGN.US): 0.142
• Moderna (MRNA.US): 1.69
• Vir Biotechnology (VIR.US): 0.457

Dyne Therapeutics overview

Dyne Therapeutics, Inc. , a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts. .

Frequently asked questions

null
What percentage of Dyne Therapeutics is owned by insiders or institutions?
Currently 0.774% of Dyne Therapeutics shares are held by insiders and 112.609% by institutions. How many people work for Dyne Therapeutics?
Latest data suggests 173 work at Dyne Therapeutics. When does the fiscal year end for Dyne Therapeutics?
Dyne Therapeutics's fiscal year ends in December. Where is Dyne Therapeutics based?
Dyne Therapeutics's address is: 1560 Trapelo Road, Waltham, MA, United States, 02451 What is Dyne Therapeutics's ISIN number?
Dyne Therapeutics's international securities identification number is: US26818M1080 What is Dyne Therapeutics's CUSIP number?
Dyne Therapeutics's Committee on Uniform Securities Identification Procedures number is: 26817G300